JM
Jay Moorin
10% Owner
Jay Moorin10% Owner
Jay Moorin insider trades: UroGen Pharma (URGN) stock buys and sales
10% Owner, UroGen Pharma Last trade Nov 28, 2017 82 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
85
Open-market trades
since 2005
14
Companies
last trade 2017
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jay reports to the SEC
URGNUroGen Pharma
10% Owner · last filing Nov 29, 2017
-$8.5M
EGRXEagle Pharmaceuticals
10% Owner · last filing May 15, 2017
-$94.4M
+$5.0M
AGRXAgile Therapeutics
10% Owner · last filing Jan 29, 2016
+$14.0M
ARNIArno Therapeutics
Director · last filing Jan 14, 2016
No market trades
IMDZImmune Design
10% Owner · last filing May 13, 2015
-$20.4M
+$4.7M
PGSIPegasi Energy Resources
Director · last filing Jan 20, 2015
No market trades
and 8 more companies
Open-market buys and sales
85 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 28, 2017 | URGN | ↓ Sell | 209,298 | $40.60 | $8.5M | Direct | Nov 29, 2017 (1d) |
| Apr 25, 2017 | EGRX | ↓ Sell | 54,180 | $88.38 | $4.8M | By ProQuest Financial LLC | Apr 27, 2017 (2d) |
| Apr 3, 2017 | EGRX | ↓ Sell | 91,332 | $83.09 | $7.6M | By ProQuest Investments IV, L.P. | Apr 3, 2017 (0d) |
| Mar 29, 2017 | EGRX | ↓ Sell | 102,668 | $83.01 | $8.5M | By ProQuest Investments IV, L.P. | Mar 29, 2017 (0d) |
| Mar 29, 2017 | EGRX | ↓ Sell | 2,900 | $83.01 | $241K | By Jay Moorin through IRA | Mar 29, 2017 (0d) |
| Mar 29, 2017 | EGRX | ↓ Sell | 900 | $83.01 | $75K | By ProQuest Financial LLC | Mar 29, 2017 (0d) |
| Mar 23, 2017 | EGRX | ↓ Sell | 1,200 | $83.05 | $100K | By ProQuest Investments IV, L.P. | Mar 23, 2017 (0d) |
| Mar 20, 2017 | EGRX | ↓ Sell | 61,003 | $82.10 | $5.0M | By ProQuest Investments IV, L.P. | Mar 20, 2017 (0d) |
| Mar 17, 2017 | EGRX | ↓ Sell | 38,997 | $82.01 | $3.2M | By ProQuest Investments IV, L.P. | Mar 20, 2017 (3d) |
| Jan 4, 2017 | EGRX | ↓ Sell | 65,114 | $85.16 | $5.5M | By ProQuest Investments IV, L.P. | Jan 6, 2017 (2d) |
| Nov 11, 2016 | EGRX | ↓ Sell | 32,886 | $85.16 | $2.8M | By ProQuest Investments IV, L.P. | Nov 14, 2016 (3d) |
| Nov 10, 2016 | EGRX | ↓ Sell | 1,300 | $85.00 | $111K | By Jay Moorin through IRA | Nov 14, 2016 (4d) |
| Nov 10, 2016 | EGRX | ↓ Sell | 300 | $85.00 | $26K | By ProQuest Financial LLC | Nov 14, 2016 (4d) |
| Nov 9, 2016 | EGRX | ↓ Sell | 153,830 | $79.29 | $12.2M | By ProQuest Investments IV, L.P. | Nov 9, 2016 (0d) |
| Nov 4, 2016 | EGRX | ↓ Sell | 242,870 | $71.04 | $17.3M | By ProQuest Investments IV, L.P. | Nov 4, 2016 (0d) |
| Nov 2, 2016 | EGRX | ↓ Sell | 2,100 | $70.00 | $147K | By Jay Moorin through IRA | Nov 4, 2016 (2d) |
| Nov 2, 2016 | EGRX | ↓ Sell | 800 | $70.00 | $56K | By ProQuest Financial LLC | Nov 4, 2016 (2d) |
| Sep 30, 2016 | EGRX | ↓ Sell | 22,100 | $70.06 | $1.5M | By ProQuest Investments IV, L.P. | Oct 4, 2016 (4d) |
| Sep 29, 2016 | EGRX | ↓ Sell | 77,900 | $70.04 | $5.5M | By ProQuest Investments IV, L.P. | Sep 30, 2016 (1d) |
| Sep 21, 2016 | EGRX | ↓ Sell | 98,947 | $66.17 | $6.5M | By ProQuest Investments IV, L.P. | Sep 23, 2016 (2d) |
| Sep 21, 2016 | EGRX | ↓ Sell | 654 | $66.17 | $43K | By Jay Moorin through IRA | Sep 23, 2016 (2d) |
| Sep 21, 2016 | EGRX | ↓ Sell | 194 | $66.17 | $13K | By ProQuest Financial LLC | Sep 23, 2016 (2d) |
| Sep 8, 2016 | EGRX | ↓ Sell | 46,020 | $62.57 | $2.9M | By ProQuest Investments IV, LP | Sep 8, 2016 (0d) |
| Sep 8, 2016 | EGRX | ↓ Sell | 465 | $62.50 | $29K | By Jay Moorin through IRA | Sep 8, 2016 (0d) |
| Sep 8, 2016 | EGRX | ↓ Sell | 137 | $62.50 | $9K | By ProQuest Financial LLC | Sep 8, 2016 (0d) |
| Sep 7, 2016 | EGRX | ↓ Sell | 24,303 | $62.36 | $1.5M | By ProQuest Investments IV, L.P. | Sep 8, 2016 (1d) |
| Aug 24, 2016 | EGRX | ↓ Sell | 28,624 | $63.00 | $1.8M | By ProQuest Investments IV, L.P. | Aug 25, 2016 (1d) |
| Aug 24, 2016 | EGRX | ↓ Sell | 189 | $62.98 | $12K | By Jay Moorin through IRA | Aug 25, 2016 (1d) |
| Aug 24, 2016 | EGRX | ↓ Sell | 57 | $62.98 | $4K | By ProQuest Financial LLC | Aug 25, 2016 (1d) |
| Aug 17, 2016 | EGRX | ↓ Sell | 82,280 | $61.53 | $5.1M | By ProQuest Investments IV, L.P. | Aug 17, 2016 (0d) |
| Aug 17, 2016 | EGRX | ↓ Sell | 653 | $60.79 | $40K | By Jay Moorin through IRA | Aug 17, 2016 (0d) |
| Aug 17, 2016 | EGRX | ↓ Sell | 146 | $60.82 | $9K | By ProQuest Financial LLC | Aug 17, 2016 (0d) |
| Aug 15, 2016 | EGRX | ↓ Sell | 16,667 | $60.51 | $1.0M | By ProQuest Investments IV, L.P. | Aug 17, 2016 (2d) |
| Aug 15, 2016 | EGRX | ↓ Sell | 49 | $60.70 | $3K | By ProQuest Financial LLC | Aug 17, 2016 (2d) |
| May 13, 2016 | EGRX | ↓ Sell | 13,980 | $40.92 | $572K | By ProQuest Management LLC Plans | May 16, 2016 (3d) |
| May 12, 2016 | EGRX | ↓ Sell | 4,000 | $40.00 | $160K | By ProQuest Management LLC Plans | May 16, 2016 (4d) |
| Jan 27, 2016 | AGRX | ↑ Buy | 393,700 | $6.35 | $2.5M | Indirect | Jan 29, 2016 (2d) |
| May 12, 2015 | IMDZ | ↓ Sell | 177,607 | $21.60 | $3.8M | Direct | May 13, 2015 (1d) |
| Apr 24, 2015 | IMDZ | ↓ Sell | 82,892 | $26.81 | $2.2M | Direct | Apr 24, 2015 (0d) |
| Apr 21, 2015 | IMDZ | ↓ Sell | 45,820 | $26.51 | $1.2M | Direct | Apr 21, 2015 (0d) |
| Apr 16, 2015 | IMDZ | ↓ Sell | 53,914 | $28.23 | $1.5M | Direct | Apr 16, 2015 (0d) |
| Apr 7, 2015 | IMDZ | ↓ Sell | 7,495 | $26.72 | $200K | Direct | Apr 8, 2015 (1d) |
| Apr 1, 2015 | IMDZ | ↓ Sell | 62,454 | $26.37 | $1.6M | Direct | Apr 2, 2015 (1d) |
| Mar 25, 2015 | IMDZ | ↓ Sell | 18,156 | $27.64 | $502K | Direct | Mar 26, 2015 (1d) |
| Mar 23, 2015 | IMDZ | ↓ Sell | 44,464 | $27.52 | $1.2M | Direct | Mar 23, 2015 (0d) |
| Mar 18, 2015 | IMDZ | ↓ Sell | 50,309 | $26.09 | $1.3M | Direct | Mar 18, 2015 (0d) |
| Mar 12, 2015 | IMDZ | ↓ Sell | 129,342 | $24.94 | $3.2M | Direct | Mar 12, 2015 (0d) |
| Mar 9, 2015 | IMDZ | ↓ Sell | 39,446 | $25.45 | $1.0M | Direct | Mar 9, 2015 (0d) |
| Jan 23, 2015 | AGRX | ↑ Buy | 811,966 | $5.85 | $4.8M | Indirect | Jan 23, 2015 (0d) |
| Jul 29, 2014 | IMDZ | ↑ Buy | 391,131 | $12.00 | $4.7M | Direct | Jul 31, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other URGN insiders
Open-market trades in the last 12 months
About Jay Moorin's insider trades
Jay Moorin is a 10% owner of UroGen Pharma (URGN). Since Oct 28, 2005, Jay has reported 18 open-market purchases worth $31.0M and 67 sales worth $138.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (15 filings), grants and awards (6 filings), conversions (6 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every URGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.